https://www.scmp.com/business/china-business/article/3335836/chinas-fosun-pharma-unit-strikes-us21-billion-obesity-drug-deal-pfizer?module=top_story&pgtype=subsection
China’s Fosun Pharma unit strikes US$2.1 billion obesity drug deal with Pfizer | South China...
Dec 10, 2025 - Yao Pharma’s deal with the US pharmaceutical giant underscores China’s growing role in global biotech licensing.
unit strikesbillion obesityus
https://www.forbes.com/sites/amyfeldman/2026/01/04/how-a-wall-street-analyst-started-a-4-billion-obesity-drug-company/
How A Wall Street Analyst Started A $4 Billion Obesity Drug Company
Jan 4, 2026 - Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and the GLP-1 space booming, it’s...
wall street analyststarted